| License: Creative Commons Attribution 3.0 PDF - Published Version (782kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-295288
- DOI to cite this document:
- 10.5283/epub.29528
Alternative links to fulltext:DOI
Abstract
Vascular and metabolic diseases cause half of total mortality in Europe. New prognostic markers would provide a valuable tool to improve outcome. First evidence supports the usefulness of plasma lipid species as easily accessible markers for certain diseases. Here we analyzed association of plasma lipid species with mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. ...

Owner only: item control page